| Filed | Description | |
|---|---|---|
| 1/16/26 | 1.01 Material Agreement | → |
| 10/21/25 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 6/20/25 | 1.01 Material Agreement | → |
| 6/17/25 | 1.01 Material Agreement | → |
| 3/4/25 | 1.01 Material Agreement | → |
| 2/18/25 | 1.012.03 Material Agreement · New Debt Obligation | → |
| ↓ 12 more | ||
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers.